Is No One Doing Baby Aspirin for Heart Disease Prevention Anymore?
For decades, a daily low-dose aspirin—often called “baby aspirin”—was a cornerstone of heart disease prevention. Millions of adults over 50 took the tiny pill as a simple, inexpensive way to reduce their risk of heart attack or stroke. But in recent years, the medical consensus around this practice has shifted dramatically. Cardiologists and major health organizations are now urging most healthy adults to stop taking aspirin preventively, citing new evidence that the risks may outweigh the benefits for many people.
This reversal reflects a broader trend in medicine: the move away from one-size-fits-all recommendations toward more personalized care. “The days of blanket aspirin prescriptions for primary prevention are over,” says Dr. Erin Michos, associate director of preventive cardiology at Johns Hopkins Medicine, in a 2023 interview with the American Heart Association. “We now have clearer data showing that for most people without existing heart disease, the potential harms—like bleeding—are too significant to justify routine use.”
The shift has left many patients confused. If aspirin was once considered a safe, proactive step, why are doctors now pulling back? And who, if anyone, should still be taking it? Here’s what the latest guidelines say—and what it means for your heart health.
The Rise and Fall of Aspirin for Primary Prevention
Aspirin’s role in heart health dates back to the 1980s, when studies first suggested that its blood-thinning properties could assist prevent clots that lead to heart attacks and strokes. By the 1990s, the American Heart Association (AHA) and the American College of Cardiology (ACC) began recommending low-dose aspirin (typically 75–100 mg) for adults at high risk of cardiovascular disease. The logic was straightforward: aspirin’s antiplatelet effects could reduce the risk of a first heart attack or stroke by about 10–20%, according to early trials.
But over time, researchers noticed a troubling pattern. While aspirin did reduce cardiovascular events, it also increased the risk of bleeding—particularly in the stomach, intestines, and brain. A 2018 meta-analysis published in The Lancet found that for every 1,000 people taking aspirin for primary prevention, it prevented 7 heart attacks or strokes but caused 8 major bleeding events. For people at low or average risk of heart disease, the math no longer added up.
The turning point came in 2019, when three major trials—ARRIVE, ASCEND, and ASPREE—all failed to show a net benefit for aspirin in primary prevention. The ASPREE trial, which focused on adults over 70, even found that aspirin was associated with a higher risk of death from all causes, including cancer. These findings prompted the AHA and ACC to update their guidelines in 2019, recommending against routine aspirin use for primary prevention in most adults.
Who Should Still Take Aspirin?
Despite the shift, aspirin isn’t disappearing from medicine cabinets entirely. The 2022 AHA/ACC guidelines still recommend low-dose aspirin for two groups:
- People with established cardiovascular disease: This includes those who have already had a heart attack, stroke, or been diagnosed with coronary artery disease. For these patients, aspirin’s benefits in preventing a second event still outweigh the risks.
- High-risk adults without heart disease: In rare cases, doctors may prescribe aspirin for people with a remarkably high risk of heart disease—such as those with diabetes and multiple risk factors—if they have a low risk of bleeding. This decision should be made on a case-by-case basis.
For everyone else, the guidelines are clear: “Aspirin should not be used for primary prevention in adults over 60,” the AHA states. For adults aged 40–59, the decision should be individualized, weighing the potential benefits against the risk of bleeding. The U.S. Preventive Services Task Force (USPSTF) echoed this stance in its 2022 update, recommending against initiating aspirin for primary prevention in adults 60 and older and suggesting that those aged 40–59 with a 10% or greater 10-year cardiovascular risk discuss it with their doctor.
Why the Change? The Risks of Aspirin
The primary concern with aspirin is bleeding. The drug works by inhibiting platelets, which help blood clot. While this reduces the risk of clots forming in arteries, it also makes it harder for the body to stop bleeding when injuries occur. The most serious risks include:
- Gastrointestinal bleeding: Aspirin can irritate the stomach lining and cause ulcers, leading to internal bleeding. This risk increases with age and is higher in people who smoke, drink alcohol, or take other medications like NSAIDs (e.g., ibuprofen).
- Hemorrhagic stroke: While aspirin reduces the risk of ischemic strokes (caused by clots), it slightly increases the risk of hemorrhagic strokes (caused by bleeding in the brain).
- Other bleeding complications: Aspirin can increase the risk of bleeding during surgery or dental procedures, and it may interact with other blood-thinning medications.
For people without existing heart disease, these risks often outweigh the potential benefits. “We used to think of aspirin as a benign, over-the-counter medication,” says Dr. Roger Blumenthal, co-chair of the 2019 ACC/AHA guideline committee. “But we now realize that even low doses can cause serious harm in some people.”
What Should You Do If You’re Taking Aspirin?
If you’re currently taking aspirin for primary prevention, don’t stop abruptly—doing so could increase your risk of a clot-related event. Instead, schedule a conversation with your doctor to review your risk factors. Key questions to ask include:
- Do I have a history of heart disease or stroke? If not, aspirin may no longer be recommended.
- What is my 10-year risk of a heart attack or stroke? Tools like the ACC’s ASCVD Risk Estimator can help assess this.
- Do I have risk factors for bleeding, such as a history of ulcers, liver disease, or uncontrolled high blood pressure?
- Am I taking other medications that could interact with aspirin, such as blood thinners or NSAIDs?
For many people, the conversation will lead to discontinuing aspirin. But for others—particularly those with existing heart disease or a very high risk of cardiovascular events—the benefits may still justify its use. “The decision should be personalized,” says Dr. Michos. “It’s not about age or a single risk factor. it’s about your overall health profile.”
Alternatives to Aspirin for Heart Health
If aspirin is no longer recommended for you, We find other evidence-based ways to reduce your risk of heart disease:
- Statins: These cholesterol-lowering medications are highly effective at reducing cardiovascular risk and are recommended for many adults with high cholesterol or other risk factors. Unlike aspirin, statins do not increase bleeding risk.
- Blood pressure control: High blood pressure is a major risk factor for heart disease and stroke. Lifestyle changes (like reducing salt intake and exercising) and medications (such as ACE inhibitors or beta-blockers) can help preserve it in check.
- Lifestyle changes: Quitting smoking, eating a heart-healthy diet (like the Mediterranean diet), maintaining a healthy weight, and getting regular exercise can all significantly reduce cardiovascular risk.
- Diabetes management: For people with diabetes, controlling blood sugar levels is critical to preventing heart disease.
“The best way to prevent heart disease isn’t a pill—it’s a healthy lifestyle,” says Dr. Blumenthal. “Aspirin was never a substitute for the basics, and now we have even more reason to focus on what really works.”
Key Takeaways
- Aspirin is no longer recommended for primary prevention (preventing a first heart attack or stroke) in most healthy adults, due to the risk of bleeding.
- It is still recommended for secondary prevention (preventing a second event) in people with existing heart disease or a very high risk of cardiovascular events.
- The decision to take aspirin should be personalized and made in consultation with a doctor, based on your individual risk factors.
- Alternatives to aspirin for heart health include statins, blood pressure control, lifestyle changes, and diabetes management.
- If you’re currently taking aspirin for primary prevention, talk to your doctor before stopping.
What’s Next?
The shift away from aspirin for primary prevention is unlikely to reverse. Ongoing research is focused on identifying subgroups of people who might still benefit from aspirin, as well as exploring new ways to prevent heart disease without increasing bleeding risk. In the meantime, the AHA and ACC continue to update their guidelines as new evidence emerges.
For now, the message is clear: aspirin is no longer a one-size-fits-all solution. If you’re taking it—or considering it—talk to your doctor to develop sure it’s the right choice for you.
Have you recently discussed aspirin with your doctor? Share your experience in the comments below, and don’t forget to share this article with friends or family who might be wondering about their heart health.